Reye's syndrome: The case for a causal link with aspirin

Drug Safety

Volumn 29, Issue 12, 2006, Pages 1111-1121

  Glasgow, John F T ^a,b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ROYAL BELFAST HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AFLATOXIN; PARACETAMOL; VALPROIC ACID;

CONNECTIVE TISSUE DISEASE; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; DRUG FORMULATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; DRUG SENSITIVITY; ENZYME INHIBITION; EPIDEMIC; FATTY ACID OXIDATION; FEVER; FIBROBLAST; HEALTH HAZARD; HEALTH SURVEY; HUMAN; INFLUENZA; LOW DRUG DOSE; METHODOLOGY; MUCOCUTANEOUS LYMPH NODE SYNDROME; OXIDATION; POLITICS; PRIORITY JOURNAL; REVIEW; REYE SYNDROME; RISK ASSESSMENT; RISK FACTOR; SELF MEDICATION; UNITED KINGDOM; VIRUS INFECTION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CHILD; GREAT BRITAIN; HUMANS; REYE SYNDROME; UNITED STATES;

EID: 33845389394     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200629120-00003     Document Type: Review

References (57)

1. Sullivan-Bolyai JZ, Corey L. Epidemiology of Reye's syndrome. Epidemiol Rev 1981; 3: 1-26
2. Glasgow JFT, Hall SM. Reye syndrome and aspirin. In: Rainsford KD, editor. Aspirin and related drugs. London: Taylor and Francis, 2004: 555-585
3. Glasgow JFT, Middleton B, Moore R, et al. The mechanism of inhibition of β-oxidation by aspirin metabolites in skin fibro-blasts from Reye's syndrome patients and controls. Biochimica et Biophysica Acta 1999; 1454: 115-25
4. Orlowski JP, Hanhan UA, Fiallos MR. Is aspirin a cause of Reye syndrome? A case against. Drug Saf 2002; 25: 225-31
5. Starko KM, Ray CG, Dominguez LB, et al. Reye's syndrome and salicylate use. Pediatrics 1980; 66: 859-64
6. Waldman RJ, Hall WN, McGee H, et al. Aspirin as a risk factor in Reye's syndrome. JAMA 1982; 247: 3089-94
7. Halpin TJ, Holtzhauer FJ, Campbell RJ, et al. Reye's syndrome and medication use. JAMA 1982; 248: 687-91
8. Hurwitz ES, Barrett MJ, Bregman D, et al. Public Health Service study on Reye's syndrome and medications: report of the pilot phase. N Engl J Med 1985; 313: 849-57
9. Hurwitz ES, Barrett MJ, Bregman D, et al. Public Health Service study of Reye's syndrome and medications: report of the main study [published erratum appears in JAMA 1987 Jun 26; 257 (24): 3366]. JAMA 1987; 257: 1905-11
10. Forsyth BW, Horwitz RI Acampora D, et al. New epidemiologic evidence confirming that bias does not explain the aspirin/Reye's syndrome association. JAMA 1989; 261: 2517-24
11. Reye RDK, Morgan G, Baral J. Encephalopathy and fatty degeneration of the viscera. A disease entity in childhood. Lancet 1963; 2: 749-52
12. National Reyes Syndrome Foundation UK. Workshop on Reye's syndrome and Reye-like inherited disorders [online]. Available from URL: www.reyessyndrome. co.uk [Accessed 2006 Nov 8]
13. Glasgow JFT. Clinical features and prognosis of Reye's syndrome. Arch Dis Child 1984; 59: 230-5
14. Hall SM, Lynn R. Reye syndrome. In: Lynn R, Nicoll A, Rahi J, et al., editors. British Paediatric Surveillance Unit, 15th Annual Report. RCPCH, London 2002: 27-30
15. Centers for Disease Control(CDC). Surgeon General's advisory on the use of salicylates and Reye syndrome. MMWR Morb Mortal Wkly Rep 1982 Jun 11; 31 (22): 289-90.
16. White JM. Reye's syndrome and salicylates. N Engl J Med 1986; 314: 920
17. Hall SM, Plaster PA, Glasgow JFT, et al. Pre-admission antipy retics in Reye's syndrome. Arch Dis Child 1988; 63: 857-66
18. CSM update: Reye's syndrome and aspirin. BMJ 1986; 292: 1590
19. Aspirin and Reye's syndrome in children up to and including 15 years of age. Current Problems in Vigilance's 2002; 28: 4
20. Hall SM, Lynn R. Reye syndrome [letter]. New Eng J Med 1999; 341: 845
21. Medicines and Healthcare products Regulatory Agency [online]. Available from URL: http://www.mhra.gov.uk [Accessed 2006 Nov 6]
22. Department of Health. Emergency planning: pandemic flu [online]. Available from URL: http://www.dh.gov.uk/Policy-AndGuidance/EmergencyPlanning/ PandemicFlu/fs/en [Accessed 2006 Nov 8]
23. Orlowski JP, Gillis J, Kilham A. A catch in the Reye. Pediatrics 1987; 80: 638-42
24. Orlowski JP, Campbell P, Goldstein S. Reye's syndrome: a case control study of medication use and associated viruses in Australia. Cleve Clin J Med 1990; 57: 323-9
25. Committee on Reye's syndrome research 1983. Japanese Ministry of Health and Welfare Official Report. Unpublished
26. Baral J. Aspirin and Reye syndrome [letter]. Pediatrics 1988; 82: 135
27. Hall SM. Reye study criticized [letter]. Pediatrics 1988; 82: 391-4
28. McGee HB, Sienko DG. A catch in the Reye. Pediatrics 1988; 82: 390-9
29. Hurwitz ES, Mortimer EA. A catch in the Reye is awry. Cleve Clin J Med 1990; 57: 318-9
30. Orlowski JP. What happened to Reye's syndrome? Did it ever really exist? Crit Care Med 1999; 27: 1582-7
31. Rennebohm RM, Heubi JE, Daugherty CC, et al. Reye syndrome in children receiving salicylate therapy for connective tissue disease. Journal of Pediatrics 1985; 107: 877-80
32. Belay ED, Bresee JS, Holman RC, et al. Reye's syndrome in the United States from 1981 through 1997. N Engl J Med 1999; 340: 1377-82
33. Stumpf DA. Reye syndrome: an international perspective. Brain and Development 1995, 78
34. Hardie RM, Newton LH, Bruce JC, et al. The changing clinical pattern of Reye's syndrome 1982-1990. Arch Dis Child 1996; 74: 400-5
35. Clark J, Nagamori K, Fitzgerald JF. Confirmation of serum salicylate levels in Reye's syndrome: a comparison between the Natelson colorimetric method and high performance liquid chromatography. Clinica Chimica Acta 1985; 145: 243-7
36. Pinsky PF, Hurwitz ES, Schonberger LB, et al. Reye's syndrome and aspirin: evidence for a dose-response effect. JAMA 1988; 260: 657-61
37. Casteels-Van Daele M. Reye syndrome or side-effects of anti-emetics? European J Pediatr 1991; 150: 456-9
38. Casteels-Van Daele M, Van Geet C, Wouters C, et al. Reye syndrome revisited: a descriptive term covering a group of heterogeneous disorders. Eur J Pediatr 2000 Sep; 159 (9): 641-8
39. Hall SM. Reye's syndrome [letter; comment]. BMJ 1994; 309: 411
40. Khan AS, Kent J, Schonberger LB. Aspirin and Reye's syndrome [letter]. Lancet 1993; 341: 968
41. Barrett MJ, Hurwitz ES, Schonberger LB, et al. Changing epidemiology of Reye syndrome in the United States. Pediatrics 1986; 77: 598-602
42. Remington PL, Rowley D, McGee H, et al. Decreasing trends in Reye syndrome and aspirin use in Michigan, 1979 to 1984. Pediatrics 1986; 77: 93-8
43. Soumerai SB, Ross-Degnan D, Kahn JS. Effects of professional and media warnings about the association between aspirin use in children and Reye's syndrome [review]. Milbank Quarterly 1992; 70: 155-82
44. Porter JD, Robinson PH, Glasgow JFT, et al. Trends in the incidence of Reye's syndrome and the use of aspirin. Arch Dis Child 1990; 65: 826-9
45. Casteels-Van Daele M, Eggermont E. Reye's syndrome. BMJ 1994; 308: 919-20
46. Roe CR. Metabolic disorders producing a Reye-like syndrome. In: Wood C, editor. Reye's syndrome. London: Royal Society of Medicine Services Round Table Series No 8, 1986: 85-107
47. Sarnaik AP. Reye's syndrome: hold the obituary. Crit Care Med 1999; 27: 1674-6176
48. Orlowski JP. Discussion at International Workshop: Reye's syndrome revisited. Leuven, 1996
49. Yoshida Y, Fujii M, Brown FR, et al. Effect of salicylic acid on mitochondrial-peroxisomal fatty acid catabolism. Pediatric Research 1988; 23: 338-41
50. Deschamps D, Fisch C, Fromenty B, et al. Inhibition by salicylic acid of the activation and thus oxidation of long chain fatty acids: possible role in the development of Reye's syndrome. J Pharmacol Exp Ther 1991; 259: 894-904
51. Maddaiah VT, Miller PS. Effects of ammonium chloride, salicylate, and carnitine on palmitic acid oxidation in rat liver slices. Pediatr Res 1989; 25: 119-23
52. Rognstad R. Effects of salicylate on hepatocyte lactate metabolism. Biomedica Biochimica Acta 1991; 50: 921-30
53. Partin JS, Partin JC, Schubert WK, et al. Serum salicylate concentrations in Reye's syndrome: a study of 130 biopsyproven cases. Lancet 1982; 1: 191-4
54. Meert KL, Kauffman RE, Deshmukh DR, et al. Impaired oxidative metabolism of salicylate in Reye's syndrome. Dev Pharmacol Ther 1990; 15: 57-60
55. Insel PA. Analgesic-antipyretic and antiinflammatory agents. In: Hardman JG, Limbird LE, editors. Goodman and Gilman's the pharmacological basis of therapeutics, 9th Ed. New York: McGraw-Hill, 1996; 631-7
56. Glasgow JFT, Middleton B. Reye syndrome -insights on causation and prognosis. Arch Dis Child 2001; 85: 351-3
57. Monto AS. The disappearance of Reye's syndrome: a public health triumph. N Engl J Med 1999; 340: 1423-4